Boston, MA, October 06, 2016 --(PR.com
)-- Cell expansion is defined as the production of daughter cells which basically arise from the single cell. Cell expansion process plays a key role in therapeutic development, drug screening and core research. At present, cell expansion is highly used for the expansion of stem cells in improving outcomes in transplantation and in various diseases such as rheumatoid arthritis and diabetes. Cell Expansion market is rapidly advancing at a strong growth rate, as estimated by IQ4I Research, the cell expansion global market is expected to grow at a double digit CAGR to reach $23,997 million by 2022.
Rising prevalence of chronic diseases, increasing government funding for research, increased investments in cell based products, growing number of GMP-certified production are some of the factors aiding in the growth of the market. 3D cell expansion technology and high-growth in the countries of APAC region are some of the opportunities that are propelling the growth of the market. However, high cost of cell-based products, use of unregulated products, quality issues for end users, ethical concerns regarding research on cell biology and stringent regulations are the factors that are hampering the market.
The cell expansion global market by product is segmented based on products, cell types, applications and end-users. The market by product is segmented into instruments and consumables, based on cell types the market is segmented into animal cell, human cell, bacterial cell and others, based on applications it is segmented into regenerative medicines and stem cell research, cancer studies and others. The instruments are segmented into cell expansion supporting instruments, bioreactors and automatic cell expansion systems. Cell expansion supporting equipments include flow cytometer, centrifuge, cell counters and others. Bioreactors are segmented into stirred type bioreactors, microcarrier-based anchorage-dependent stirred type bioreactors, suspension-based anchorage independent stirred type bioreactors, hollow fibre/perfusion bioreactors, bubble column and airlift bioreactor, single/disposable use bioreactor and others. Consumables are segmented into reagents, media, sera and disposables. Disposables are further sub-segmented into culture vessels, bioreactor accessories and others. Among bioreactors, single use bioreactors are expected to drive the market high with a high double digit CAGR during 2015-2022. For instance, ABEC, a U.S. based bioprocess solution company, launched a ‘Custom Single Run’ (CSR) system in November 2015, with a total volume of 4,300L and a working volume of 3,500L, making it the largest single use bioreactor available in the market.
By cell types, the cell expansion markets are divided into animal cells, human cells, bacterial cells and others. The human cell includes adult stem cells, induced pluripotent stem cells and embryonic stem cells. Adult stem cells are segmented into mesenchymal stem cells, hematopoietic stem cells and neural stem cells. Mesenchymal stem cells are expected to grow a high double digit CAGR due to increasing acceptance of stem cell therapies.
By application, the cell expansion markets are divided into regenerative medicine and stem cell research, cancer studies and others. Regenerative medicine is expected to grow at a high double digit CAGR from 2015-2022 by addressing many addressing many unmet therapeutic needs. The end users of the cell expansion market are segmented into academics and research institutes, biotechnology and biopharmaceutical companies, hospital and bio-banks and others. Hospitals and biobanks are expected to grow at a high double digit CAGR from 2015-2022.
The cell expansion global market by geography is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America commanded the largest market share in 2015 due to increase in governmental funding and investments and better accessibility to healthcare facilities has led the market growth in this region. However, Asia- Pacific region is expected to have highest growth rate from 2015-2022 due to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies.
The major players in the cell expansion global market are Becton Dickenson and Company (U.S.), Corning Inc (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), GE Healthcare (U.K.), Lonza Group (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), Stemcell Technologies (Canada), Terumo Corporation (Japan) and ThermoFisher Scientific Inc. (U.S.).